Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases

17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases

US Patent 7476681 · Granted Jan 13, 2009

Estimated economic value: $371,128,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted aminothiazoles as inhibitors of nucleases2023
4-(1H-imidazol-5-yl)-1H-pyrrolo[2, 3-b] pyridines for use in the treatment of le2022
Substituted propanamides as inhibitors of nucleases2022
Compounds useful for treating disorders related to RET2019
Pyrazolotriazines as inhibitors of nucleases2018
Furopyridines as inhibitors of protein kinases2018
Purine inhibitors of human phosphatidylinositol 3-kinase delta2017
Anilinopiperazine derivatives and methods of use thereof2015
Substituted piperidines as HDM2 inhibitors2015
Modulators of cell cycle checkpoints and their use in combination with checkpoin2015
Substituted piperidines that increase p53 activity and the uses thereof2014
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors2014